Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Senior

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Nature Biotechnology|September 15, 2023
Pharma deal making: a bright spot amid the gloomMelanie Senior
Nature Biotechnology|November 8, 2014
Big-cap buying bonanza trickles down to small biotechMelanie Senior
Nature Biotechnology|June 8, 2017
After Glybera's withdrawal, what's next for gene therapy?Melanie Senior
Nature Biotechnology|October 4, 2019
Biotech giant helps itself without swallowing Galapagos wholeMelanie Senior
Nature Biotechnology|August 1, 2022
Fighting fibrosisMelanie Senior
Nature Biotechnology|July 9, 2015
Biotechs recoil at hedge fund manager's patent attacksMelanie Senior
Nature Cancer|December 10, 2025
Cancer drug approvals and setbacks in 2025Melanie Senior
Nature Biotechnology|April 9, 2013
Biosimilars battle rages on, Amgen fights both sidesMelanie Senior
Nature Biotechnology|August 10, 2013
Spreading biotech dollars around WashingtonMelanie Senior
Nature Biotechnology|December 10, 2013
Appetite for cheaper biologics spreads across the mapMelanie Senior
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Nature Biotechnology|September 15, 2023
Pharma deal making: a bright spot amid the gloomMelanie Senior
Nature Biotechnology|November 8, 2014
Big-cap buying bonanza trickles down to small biotechMelanie Senior
Nature Biotechnology|June 8, 2017
After Glybera's withdrawal, what's next for gene therapy?Melanie Senior
Nature Biotechnology|October 4, 2019
Biotech giant helps itself without swallowing Galapagos wholeMelanie Senior
Nature Biotechnology|August 1, 2022
Fighting fibrosisMelanie Senior
Nature Biotechnology|July 9, 2015
Biotechs recoil at hedge fund manager's patent attacksMelanie Senior
Nature Cancer|December 10, 2025
Cancer drug approvals and setbacks in 2025Melanie Senior
Nature Biotechnology|April 9, 2013
Biosimilars battle rages on, Amgen fights both sidesMelanie Senior
Nature Biotechnology|August 10, 2013
Spreading biotech dollars around WashingtonMelanie Senior
Nature Biotechnology|December 10, 2013
Appetite for cheaper biologics spreads across the mapMelanie Senior
Pageof 6